These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 24104875)
1. Early short-term doxycycline therapy in patients with acute myocardial infarction and left ventricular dysfunction to prevent the ominous progression to adverse remodelling: the TIPTOP trial. Cerisano G; Buonamici P; Valenti R; Sciagrà R; Raspanti S; Santini A; Carrabba N; Dovellini EV; Romito R; Pupi A; Colonna P; Antoniucci D Eur Heart J; 2014 Jan; 35(3):184-91. PubMed ID: 24104875 [TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and their tissue inhibitor after reperfused ST-elevation myocardial infarction treated with doxycycline. Insights from the TIPTOP trial. Cerisano G; Buonamici P; Gori AM; Valenti R; Sciagrà R; Giusti B; Sereni A; Raspanti S; Colonna P; Gensini GF; Abbate R; Schulz R; Antoniucci D Int J Cardiol; 2015 Oct; 197():147-53. PubMed ID: 26134371 [TBL] [Abstract][Full Text] [Related]
3. Effects of a timely therapy with doxycycline on the left ventricular remodeling according to the pre-procedural TIMI flow grade in patients with ST-elevation acute myocardial infarction. Cerisano G; Buonamici P; Valenti R; Moschi G; Taddeucci E; Giurlani L; Migliorini A; Vergara R; Parodi G; Sciagrà R; Romito R; Colonna P; Antoniucci D Basic Res Cardiol; 2014 Jul; 109(4):412. PubMed ID: 24825768 [TBL] [Abstract][Full Text] [Related]
4. Association between discharge heart rate and left ventricular adverse remodelling in ST segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention. Joyce E; Hoogslag GE; Leong DP; Fox K; Schalij MJ; Marsan NA; Bax JJ; Delgado V Heart; 2013 Apr; 99(8):556-61. PubMed ID: 23468514 [TBL] [Abstract][Full Text] [Related]
5. ST-segment analysis to predict infarct size and functional outcome in acute myocardial infarction treated with primary coronary intervention and adjunctive abciximab therapy. Sciagrà R; Parodi G; Migliorini A; Valenti R; Antoniucci D; Sotgia B; Pupi A Am J Cardiol; 2006 Jan; 97(1):48-54. PubMed ID: 16377283 [TBL] [Abstract][Full Text] [Related]
6. Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: A pilot study. Gerbaud E; Montaudon M; Chasseriaud W; Gilbert S; Cochet H; Pucheu Y; Horovitz A; Bonnet J; Douard H; Coste P Arch Cardiovasc Dis; 2014 Jan; 107(1):33-41. PubMed ID: 24440004 [TBL] [Abstract][Full Text] [Related]
7. Granulocyte colony-stimulating factor attenuates left ventricular remodelling after acute anterior STEMI: results of the single-blind, randomized, placebo-controlled multicentre STem cEll Mobilization in Acute Myocardial Infarction (STEM-AMI) Trial. Achilli F; Malafronte C; Lenatti L; Gentile F; Dadone V; Gibelli G; Maggiolini S; Squadroni L; Di Leo C; Burba I; Pesce M; Mircoli L; Capogrossi MC; Di Lelio A; Camisasca P; Morabito A; Colombo G; Pompilio G; Eur J Heart Fail; 2010 Oct; 12(10):1111-21. PubMed ID: 20861135 [TBL] [Abstract][Full Text] [Related]
8. Predictors of ventricular remodelling in patients with reperfused acute myocardial infarction and left ventricular dysfunction candidates for bone marrow cell therapy: insights from the BONAMI trial. Manrique A; Lemarchand P; Delasalle B; Lairez O; Sportouch-Duckan C; Lamirault G; Le Corvoisier P; Neuder Y; Richardson M; Lebon A; Roncalli J; Piot C; Trochu JN; Teiger E; Hossein-Foucher C; Le Tourneau T Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):740-8. PubMed ID: 26666236 [TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study. Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944 [TBL] [Abstract][Full Text] [Related]
10. Sestamibi single photon emission computed tomography immediately after primary percutaneous coronary intervention identifies patients at risk for large infarcts. Kaltoft A; Bøttcher M; Sand NP; Rehling M; Andersen NT; Zijlstra F; Nielsen TT Am Heart J; 2006 May; 151(5):1108-14. PubMed ID: 16644346 [TBL] [Abstract][Full Text] [Related]
11. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial. Ince H; Petzsch M; Kleine HD; Eckard H; Rehders T; Burska D; Kische S; Freund M; Nienaber CA Circulation; 2005 Aug; 112(9 Suppl):I73-80. PubMed ID: 16159869 [TBL] [Abstract][Full Text] [Related]
12. Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Ørn S; Ueland T; Manhenke C; Sandanger Ø; Godang K; Yndestad A; Mollnes TE; Dickstein K; Aukrust P J Intern Med; 2012 Sep; 272(3):267-76. PubMed ID: 22243053 [TBL] [Abstract][Full Text] [Related]
13. Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction. Nilsson L; Hallén J; Atar D; Jonasson L; Swahn E Heart; 2012 Jan; 98(1):31-6. PubMed ID: 21727201 [TBL] [Abstract][Full Text] [Related]
14. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Ganame J; Messalli G; Dymarkowski S; Rademakers FE; Desmet W; Van de Werf F; Bogaert J Eur Heart J; 2009 Jun; 30(12):1440-9. PubMed ID: 19346229 [TBL] [Abstract][Full Text] [Related]
15. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. Schömig A; Mehilli J; Antoniucci D; Ndrepepa G; Markwardt C; Di Pede F; Nekolla SG; Schlotterbeck K; Schühlen H; Pache J; Seyfarth M; Martinoff S; Benzer W; Schmitt C; Dirschinger J; Schwaiger M; Kastrati A; JAMA; 2005 Jun; 293(23):2865-72. PubMed ID: 15956631 [TBL] [Abstract][Full Text] [Related]
16. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy. Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832 [TBL] [Abstract][Full Text] [Related]
17. Stem cells mobilization in acute myocardial infarction (stem-AMI trial): preliminary data of a perspective, randomized, single blind trial. Malafronte C; Achilli F Minerva Cardioangiol; 2007 Dec; 55(6):721-31. PubMed ID: 18091641 [TBL] [Abstract][Full Text] [Related]
18. Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial. Kaltoft A; Bøttcher M; Nielsen SS; Hansen HH; Terkelsen C; Maeng M; Kristensen J; Thuesen L; Krusell LR; Kristensen SD; Andersen HR; Lassen JF; Rasmussen K; Rehling M; Nielsen TT; Bøtker HE Circulation; 2006 Jul; 114(1):40-7. PubMed ID: 16801464 [TBL] [Abstract][Full Text] [Related]
19. Early changes of left ventricular filling pattern after reperfused ST-elevation myocardial infarction and doxycycline therapy: Insights from the TIPTOP trial. Cerisano G; Buonamici P; Parodi G; Santini A; Moschi G; Valenti R; Migliorini A; Colonna P; Bellandi B; Gori AM; Antoniucci D Int J Cardiol; 2017 Aug; 240():43-48. PubMed ID: 28433557 [TBL] [Abstract][Full Text] [Related]
20. Aspiration coronary thrombectomy for acute myocardial infarction increases myocardial salvage: single center randomized study. Ciszewski M; Pregowski J; Teresińska A; Karcz M; Kalińczuk Ł; Pracon R; Witkowski A; Rużyłło W Catheter Cardiovasc Interv; 2011 Oct; 78(4):523-31. PubMed ID: 21234920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]